The alterations of glycosylation in malignant diseases;Zaburzenia glikozylacji w chorobach nowotworowych

Polski Merkuriusz Lekarski

Volumn 34, Issue 199, 2013, Pages 58-61

  Gruszewska, Ewa ^a   Chrostek, Lech ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Glycosylation; Malignant diseases

Indexed keywords

ACUTE PHASE PROTEIN; POLYSACCHARIDE;

CHEMISTRY; GLYCOSYLATION; HUMAN; LIPID METABOLISM; METABOLISM; NEOPLASM; REVIEW;

ACUTE-PHASE PROTEINS; GLYCOSYLATION; HUMANS; LIPID METABOLISM; NEOPLASMS; POLYSACCHARIDES;

EID: 84874061169     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Arnold J. N., Saldova R., Abd Hamid U. M. et al.: Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomic J., 2008;8;3284-3293.
2. Dall'Olio F.: Protein glycosylation in cancer biology: an overview. Clin. Molec. Path., 1996;49;126-135.
3. Dall'Olio F., Malagolini N., Chiricolo M.: Glycosylation in cancer. In: Carbohydrate Chemistry. Rauter A. P. (ed.). Royal Society Chemistry, Cambridge, 2012;37;21-56.
4. Drake P. M., Cho W., Li B. et al.: Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem., 2010;56;223-236.
5. Hakomori S.: Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res., 1985;45;2405-2414.
6. Hakomori S.: Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. Natl. Acad. Sci. USA, 2002;99;10231-10233.
7. Jonckheere N., Skrypek N., Van Seuningen I.: Mucins and pancreatic cancer. Cancers, 2010;2;1794-1812.
8. Kaczmarek R.: Zmiany ekspresji antygenów grupowych układu Lewis w komórkach nowotworowych. Post. Hig. Med. Dosw., 2010;64;87-99.
9. Kannagi R.: Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression - The Warburg effect revisited. Glycoconj. J., 2004;20;353-364.
10. Ka̧tnik-Prastowska I., Ferens-Sieczkowska M.: Diagnostyczne perspektywy określania zmian w glikozylacji białek. Dagn. Lab., 1999;35;339-350.
11. Kim M. J., Kim H. S., Song K. S. et al.: Altered expression of Lewis antigen on tissue and erythrocytes in gastric cancer patients. Yonsei Med. J., 2002;43;427-434.
12. Kim Y. J., Varki A.: Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj. J., 1997;14;569-576.
13. Laidler P., Lityńska A.: Tumor cell N-glycans in metastasis. Acta Biochim. Polon., 1997;44;343-358.
14. Lis H., Sharon N.: Protein glycosylation: structural and functional aspects. Eur. J. Biochem., 1993;218;1-27.
15. Mackiewicz A., Mackiewicz K.: Glycoforms of serum a1-acid glycoprotein as markers of inflammation and cancer. Glycoconj. J., 1995;12;241-247.
16. Mariano A., Di Carlo A., Santonastaso C. et al.: Expression of Lewis carbohydrate antigens and chromogranin A in human prostatic cancer. Int. J. Oncol., 2000;17;167-171.
17. Mas E., Pasqualini E., Caillol N. et al.: Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines. Glycobiology, 1998;8;605-613.
18. Meany D., Chan D. W.: Aberrant glycosylation associated with enzymes as cancer biomarkers. Clinical Proteomics, 2011;8;1-14.
19. Miyagi T., Wada T., Yamaguchi K. et al.: Sialidase and malignancy: a minireview. Glycoconj. J., 2004;20;189-198.
20. Narayanan S.: Sialic acid as a tumor marker. Ann. Clin. Lab. Sci., 1994;24;376-384.
21. Okuyama N., Ide Y, Nakano M. et al.: Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer., 2006;118;2803-2808.
22. Orczyk-Pawiłowicz M.: Znaczenie fukozylacji glikokoniugatów w zdrowiu i chorobie. Post. Hig. Med. Dosw., 2007;61;240-252.
23. Saitoh A., Aoyagi Y, Asakura H.: Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennarry glycan in hepatocellular carcinoma. Arch. Biochem. Biophys., 1993;303;281-287.
24. Taketa K., Sekiya C, Namiki M. et al.: Lectin-reactive profile of alphafetoprotein characterizing hepatocellular-carcinoma and related conditions. Gastroenterology, 1990;99;508-518.
25. Van Dijk W., Turner G. A., Mackiewicz A.: Changes in glycosylation of acute-phase proteins in health and disease: occurrence, regulation and function. Glycosylation and disease, 1994;1;5-14.
26. Varki A., Kannagi R., Toole B. P.: Glycosylation changes in cancer. In: Essentials of glycobiology. Varki A., Cummings R. D., Esko J. D. et al. (eds.). 2. Cold Spring Harbor Laboratory Press, New York, 2008;617-632.
27. Wang P.: Altered glycosylation in cancer: sialic acid and sialyltransferases. J. Cancer Mol., 2005;1;73-81.
28. Wang P.: Altered sialylation and its roles in gynecologic cancers. J. Cancer Mol., 2006;2;107-116.